Sneha Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sneha Singh has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Abhimanyu Dev
Department of Pharmaceutical Sciences & Technology, Birla Institute of Technology, Mesra, Ranchi, Jharkhand, 835215, India
7 shared publications Archita Gupta
Department of Bioengineering and Biotechnology, Birla Institute of Technology, Mesra, Ranchi 835215, Jharkhand, India
6 shared publications- Ashok Kumar
Indian Institute of Technology Kanpur
6 shared publications - Archita Gupta
Department of Bioengineering and Biotechnology, Birla Institute of Technology, Mesra, Ranchi 835215, Jharkhand, India
4 shared publications - Harishkumar Madhyastha
Department of Cardiovascular Physiology, Faculty of Medicine, University of Miyazaki, Miyazaki 8891692, Japan
3 shared publications Prerna Singh
3 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Walter de Gruyter GmbH in Nanotechnology Reviews
- Vol. 15 (1)
Green synthesis of silver-doped CuO/CaO/ZnO nanocomposites using extract of Dalbergia sissoo, their characterization, and various applications
In this study, Dalbergia sissoo extract mediated Ag-doped CuO/CaO/ZnO nanocomposites (Ag–CuO–CaO–ZnO NCs) were synthesized using an eco-friendly approach. FTIR confirmed phytochemical-assisted reduction, while UV–Vis spectroscopy revealed a characteristic peak at 246 nm, indicating the formation of the nanocomposite. XRD and SAED revealed the crystalline structure, and SEM/TEM revealed predominantly hexagonal particles. TEM and DLS analyses revealed particle sizes ranging from 10 to 100 nm, with an average size of approximately 26 nm. EDX verified successful silver incorporation, and DSC was used to assess thermal stability. The DSAgNCs showed antioxidant activity and demonstrated potent cytotoxicity against C6 glioblastoma cells (IC 50 = 37.29 μg/mL). The Ag–CuO–CaO–ZnO NCs also exhibited significant antibacterial activity against Escherichia coli . After 120 min, the functional performance of the Ag–CuO–CaO–ZnO NCs was evaluated through the photocatalytic degradation of organic dyes including crystal violet (CV), and malachite green (MG) under light irradiation, resulting in degradation percentages of 90 and 92 %, respectively. In addition, the metal-ion sensing ability of the Ag–CuO–CaO–ZnO NCs was investigated against different metal salts, which were highly sensitive to Cd 2+ , Ca 2+ , Zn 2+ , Ni 2+ , Sr 2+ , Mg 2+ , Co 2+ , and Al 3+ . Overall, the results highlight that Ag–CuO–CaO–ZnO NCs possess multifunctional photocatalytic, sensing, and biological properties suitable for environmental remediation and biomedical applications.
- 1 January 2026
- Published by Walter de Gruyter GmbH in Nanotechnology Reviews
- Vol. 15 (1)
Open AccessGreen synthesis of silver-doped CuO/CaO/ZnO nanocomposites using extract of Dalbergia sissoo, their characterization, and various applications
In this study, Dalbergia sissoo extract mediated Ag-doped CuO/CaO/ZnO nanocomposites (Ag–CuO–CaO–ZnO NCs) were synthesized using an eco-friendly approach. FTIR confirmed phytochemical-assisted reduction, while UV–Vis spectroscopy revealed a characteristic peak at 246 nm, indicating the formation of the nanocomposite. XRD and SAED revealed the crystalline structure, and SEM/TEM revealed predominantly hexagonal particles. TEM and DLS analyses revealed particle sizes ranging from 10 to 100 nm, with an average size of approximately 26 nm. EDX verified successful silver incorporation, and DSC was used to assess thermal stability. The DSAgNCs showed antioxidant activity and demonstrated potent cytotoxicity against C6 glioblastoma cells (IC 50 = 37.29 μg/mL). The Ag–CuO–CaO–ZnO NCs also exhibited significant antibacterial activity against Escherichia coli . After 120 min, the functional performance of the Ag–CuO–CaO–ZnO NCs was evaluated through the photocatalytic degradation of organic dyes including crystal violet (CV), and malachite green (MG) under light irradiation, resulting in degradation percentages of 90 and 92 %, respectively. In addition, the metal-ion sensing ability of the Ag–CuO–CaO–ZnO NCs was investigated against different metal salts, which were highly sensitive to Cd 2+ , Ca 2+ , Zn 2+ , Ni 2+ , Sr 2+ , Mg 2+ , Co 2+ , and Al 3+ . Overall, the results highlight that Ag–CuO–CaO–ZnO NCs possess multifunctional photocatalytic, sensing, and biological properties suitable for environmental remediation and biomedical applications.
- 30 August 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 664, 124637
Osteo-modulatory potential of biologically synthesized cis-resveratrol passivated gold nanoparticles
- 30 August 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 664, 124637
Osteo-modulatory potential of biologically synthesized cis-resveratrol passivated gold nanoparticles
- 6 June 2024
- Published by Taylor & Francis
Emerging Materials and Technologies for Bone Repair and Regeneration
This book covers advancements in the field of bone repair and regeneration. It introduces bone development, repair, and regeneration and details different biomaterials and technologies involved in the fabrication and characterization of bone-related scaffolds and implants. The book explores nanotechnological intervention and folklore phytomedicines and their prospects in regenerating bone including major bone related disease conditions, infection, and their tackling via tissue engineering strategies. FEATURES: Covers polymer materials and technologies for bone repair and regeneration based on tissue engineering Defines the interdisciplinary mechanism of bone tissue repair ranging from the fields of material science, nanotechnology, and phytomedicine includes basic sciences, scaffolds, and bone infection Examines fabrication and characterization methods for the bone repair materials Reviews fundamentals of interlinked mechanisms of bone development, repair, and regeneration. This book is aimed at graduate students and researchers in biomedical and tissue engineering and biomaterial sciences.
- 6 June 2024
- Published by Taylor & Francis
Emerging Materials and Technologies for Bone Repair and Regeneration
This book covers advancements in the field of bone repair and regeneration. It introduces bone development, repair, and regeneration and details different biomaterials and technologies involved in the fabrication and characterization of bone-related scaffolds and implants. The book explores nanotechnological intervention and folklore phytomedicines and their prospects in regenerating bone including major bone related disease conditions, infection, and their tackling via tissue engineering strategies. FEATURES: Covers polymer materials and technologies for bone repair and regeneration based on tissue engineering Defines the interdisciplinary mechanism of bone tissue repair ranging from the fields of material science, nanotechnology, and phytomedicine includes basic sciences, scaffolds, and bone infection Examines fabrication and characterization methods for the bone repair materials Reviews fundamentals of interlinked mechanisms of bone development, repair, and regeneration. This book is aimed at graduate students and researchers in biomedical and tissue engineering and biomaterial sciences.
- 6 June 2024
- Published by Taylor & Francis
- p. 216-243
Modulatory Effects of Phytobioactives in Bone Metabolism and Regeneration
Bone metabolism is a complex process of tissue mineralization and resorption. It is critical to modulate bone metabolism for efficient bone healing and treating bone injuries. Bone has self-regenerating potential, but traumatic events require intervention therapy for healing bones. Plant-derived secondary metabolites or phytobioactives comprise a group of phytoconstituents with promising bone-remodeling properties. Moreover, phytobioactives provide an easily available, cost-effective, and biocompatible alternative therapy for bone healing, overcoming the limitations posed by synthetic osteo-active compounds. Although phytobioactives have been traditionally used for treating bone fractures, recently, different phytobioactives are emerging as new therapeutic agents to modulate different mechanistic pathways involved in bone metabolism. This chapter elaborately discusses different phytobioactives, their structural roles in modulating bone metabolism, and their respective isolation procedures. Furthermore, the effect of the constituents on repairing bone tissues is also explained via different in vitro and in vivo models. The chapter also highlights the promising local delivery strategies that have enhanced the bioavailability of the osteogenic phytobioactives. Phytobioactives-based orthobiologics will assist in designing advanced treatment strategies in bone tissue engineering.
- 6 June 2024
- Published by Taylor & Francis
- p. 216-243
Modulatory Effects of Phytobioactives in Bone Metabolism and Regeneration
Bone metabolism is a complex process of tissue mineralization and resorption. It is critical to modulate bone metabolism for efficient bone healing and treating bone injuries. Bone has self-regenerating potential, but traumatic events require intervention therapy for healing bones. Plant-derived secondary metabolites or phytobioactives comprise a group of phytoconstituents with promising bone-remodeling properties. Moreover, phytobioactives provide an easily available, cost-effective, and biocompatible alternative therapy for bone healing, overcoming the limitations posed by synthetic osteo-active compounds. Although phytobioactives have been traditionally used for treating bone fractures, recently, different phytobioactives are emerging as new therapeutic agents to modulate different mechanistic pathways involved in bone metabolism. This chapter elaborately discusses different phytobioactives, their structural roles in modulating bone metabolism, and their respective isolation procedures. Furthermore, the effect of the constituents on repairing bone tissues is also explained via different in vitro and in vivo models. The chapter also highlights the promising local delivery strategies that have enhanced the bioavailability of the osteogenic phytobioactives. Phytobioactives-based orthobiologics will assist in designing advanced treatment strategies in bone tissue engineering.
- 26 October 2022
- Published by Georg Thieme Verlag KG in Hamostaseologie
- Vol. 42 (S 01) , S32-S37
A Polycistronic Mammalian Vector/Expression System to Establish the Causality of FXIII Heterozygous Variant Species
Introduction: Coagulation factor XIII (FXIII) is a protransglutaminase that circulates in plasma as a heterotetramer comprising of two catalytic A and two carrier/regulatory B subunits. Upon activation by thrombin and calcium, FXIII crosslinks preformed fibrin clot, thereby providing mechanical resistance to the growing clot. Inherited FXIII deficiency caused by homozygous/compound heterozygous mutations in F13A1/F13B genes results in severe bleeding diathesis. On the other hand, heterozygous mutations in either FXIII genes could lead to inherited mild FXIII deficiency. Although primarily asymptomatic, mild FXIII-deficient individuals (FXIII activity < 60%) can bleed more than usual when exposed to physical trauma, i.e., perioperatively, during dental extraction etc. In the recent past, we have detected 23 missense mutations (16 in F13A1 and 7 in F13B gene) in mild FXIII-deficient individuals. We have also shown these mutations to be affecting FXIII function. However, the dominant negative effect of these mutations can only be proved by analyzing the heterozygous variant species in its pure form. In this regard, we have developed mammalian expression systems that enable simultaneous co-expression of both mutant and wild-type alleles. We further intend to selectively purify distinct allelic compositions, by exploiting the usage of differential tags. Methods: Two types of expression vector were developed for this analysis: (1) a two-promoter system with two strong cytomegalovirus promoters upstream of open reading frames (ORFs), each separated by SV40 PA translation stop site, and (2) P2A vector system in which the cloned mutant and wild type are separated by an P2A self-cleaving site. Both the mutant and wild-type ORFs were differentially tagged with 6X-His and Strep-II tags at the N- and C-terminals, respectively. Both systems will allow the simultaneous expression of mutant and wild-type alleles in the same cell upon transient transfections. This will result in the simultaneous generation of homozygous wild-type, homozygous mutant, and heterozygous variant FXIIIA2 species within the same cell. These dimeric species will be systematically segregated selectively during purification steps using the selection tags attached with the wild-type and the mutant complementary DNAs. Initially, we have cloned the previously reported mutants, FXIIIA-R612H and FXIIIA- H343Y, in both these systems and transiently transfected these plasmids into HEK293t cell lines. The intracellular proteins harvested 36 hours posttransfection were evaluated for FXIII activity and antigen levels. The remaining cellular lysates were stored for downstream chromatographic separation and functional studies. Results: Both mutations analyzed here show close to 40–60% of FXIII activity as well as antigenic levels corresponding to that of the wild type in concordance with the FXIII levels observed in the mild FXIII-deficient individuals carrying these mutations. Conclusion: Both the expression systems were able to successfully express all three expected species including the heterozygous variant species as indicated by the carrier/heterozygous activity levels observed posttransfection. Further analysis will involve the selective purification of the heterozygous variant species (FXIIIAA' dimers) and subsequently comparing it to the wild type as well as the mutant homozygous species (FXIIIA2, FXIIIA' A' dimers) with regards to the various functional aspects of FXIII. Article published online: 26 October 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 26 October 2022
- Published by Georg Thieme Verlag KG in Hamostaseologie
- Vol. 42 (S 01) , S32-S37
A Polycistronic Mammalian Vector/Expression System to Establish the Causality of FXIII Heterozygous Variant Species
Introduction: Coagulation factor XIII (FXIII) is a protransglutaminase that circulates in plasma as a heterotetramer comprising of two catalytic A and two carrier/regulatory B subunits. Upon activation by thrombin and calcium, FXIII crosslinks preformed fibrin clot, thereby providing mechanical resistance to the growing clot. Inherited FXIII deficiency caused by homozygous/compound heterozygous mutations in F13A1/F13B genes results in severe bleeding diathesis. On the other hand, heterozygous mutations in either FXIII genes could lead to inherited mild FXIII deficiency. Although primarily asymptomatic, mild FXIII-deficient individuals (FXIII activity < 60%) can bleed more than usual when exposed to physical trauma, i.e., perioperatively, during dental extraction etc. In the recent past, we have detected 23 missense mutations (16 in F13A1 and 7 in F13B gene) in mild FXIII-deficient individuals. We have also shown these mutations to be affecting FXIII function. However, the dominant negative effect of these mutations can only be proved by analyzing the heterozygous variant species in its pure form. In this regard, we have developed mammalian expression systems that enable simultaneous co-expression of both mutant and wild-type alleles. We further intend to selectively purify distinct allelic compositions, by exploiting the usage of differential tags. Methods: Two types of expression vector were developed for this analysis: (1) a two-promoter system with two strong cytomegalovirus promoters upstream of open reading frames (ORFs), each separated by SV40 PA translation stop site, and (2) P2A vector system in which the cloned mutant and wild type are separated by an P2A self-cleaving site. Both the mutant and wild-type ORFs were differentially tagged with 6X-His and Strep-II tags at the N- and C-terminals, respectively. Both systems will allow the simultaneous expression of mutant and wild-type alleles in the same cell upon transient transfections. This will result in the simultaneous generation of homozygous wild-type, homozygous mutant, and heterozygous variant FXIIIA2 species within the same cell. These dimeric species will be systematically segregated selectively during purification steps using the selection tags attached with the wild-type and the mutant complementary DNAs. Initially, we have cloned the previously reported mutants, FXIIIA-R612H and FXIIIA- H343Y, in both these systems and transiently transfected these plasmids into HEK293t cell lines. The intracellular proteins harvested 36 hours posttransfection were evaluated for FXIII activity and antigen levels. The remaining cellular lysates were stored for downstream chromatographic separation and functional studies. Results: Both mutations analyzed here show close to 40–60% of FXIII activity as well as antigenic levels corresponding to that of the wild type in concordance with the FXIII levels observed in the mild FXIII-deficient individuals carrying these mutations. Conclusion: Both the expression systems were able to successfully express all three expected species including the heterozygous variant species as indicated by the carrier/heterozygous activity levels observed posttransfection. Further analysis will involve the selective purification of the heterozygous variant species (FXIIIAA' dimers) and subsequently comparing it to the wild type as well as the mutant homozygous species (FXIIIA2, FXIIIA' A' dimers) with regards to the various functional aspects of FXIII. Article published online: 26 October 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 26 October 2022
- Published by Georg Thieme Verlag KG in Hamostaseologie
- Vol. 42 (S 01) , S32-S37
Structural Characterization of Factor VIII B Domain to Generate an All Atom Full-Length Structure of the Coagulation Factor VIII Protein
Introduction: Factor (F) VIII is a coagulation protein that contains a unique large heavily glycosylated but highly disordered B domain apart from five other globular domains. Due to high-level disorder within the B domain, it evades structural characterization by traditional structural determination techniques. Hence, we have adopted an integrated hybrid methodology that will combine bioanalytical/biophysical imaging methods such as crosslinking mass spectrometry (XL-MS), atomic force microscopy (AFM), and cryo-EM with computational modeling techniques to characterize the structure of the B domain and that of the full-length FVIII (FL-FVIII) protein. Methods: Commercial plasma-derived and recombinant FVIII products were subjected to various chromatography methods to yield a high-pure FL-FVIII protein. The pure FL-FVIII was cross-linked using DSSO cross-linker. PNGase A enzyme was used to deglycosylate the FL-FVIII to facilitate better crosslinking. Blind modeling of the B domain was carried out on the I-TASSER server. AFM imaging studies were performed for pure FL-FVIII protein in both air and liquid. Negative staining of the purified FL- FVIII followed by two-dimensional (2D) classification was done towards future cryo-EM studies. Results and Discussion: Highly pure FL-FVIII protein of yield ≈200 µg/mL was obtained devoid of all excipients such as albumin and von Willebrand factor. Successful crosslinking of the highly pure FL-FVIII with DSSO was achieved and glycosylation residues were removed towards future XL-MS data. Blind modeling by I- TASSER server generated top three B domain models which were integrated to the available B-domain-deleted FVIII crystal structure from PDB to obtain FL-FVIII models. Negative stains of FL-FVIII showed heterogeneous particles with five different classes of size and shapes illustrated by 2D classification. AFM analysis in air and liquid modes showed high-resolution structural maps with multiple conformational possibilities of FL-FVIII. Further comparison of the low- and high-resolution structural maps obtained from negative staining and AFM imaging to our blind FL-FVIII models indicated a relative position. Conclusion: The structural imaging techniques suggest conformational variability in the FL-FVIII molecule owing to the flexibility in the FVIII B domain which is in good agreement with our blind models. This gives us a high confidence that with the addition of the experimental data to improve these blind models, we will be able to arrive at an accurate representative structure of the FL-FVIII protein. * This work was funded by IIR grant awarded to PD Dr. Arijit Biswas and Prof. Johannes Oldenburg from Takeda (Shire). Article published online: 26 October 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 26 October 2022
- Published by Georg Thieme Verlag KG in Hamostaseologie
- Vol. 42 (S 01) , S32-S37
Structural Characterization of Factor VIII B Domain to Generate an All Atom Full-Length Structure of the Coagulation Factor VIII Protein
Introduction: Factor (F) VIII is a coagulation protein that contains a unique large heavily glycosylated but highly disordered B domain apart from five other globular domains. Due to high-level disorder within the B domain, it evades structural characterization by traditional structural determination techniques. Hence, we have adopted an integrated hybrid methodology that will combine bioanalytical/biophysical imaging methods such as crosslinking mass spectrometry (XL-MS), atomic force microscopy (AFM), and cryo-EM with computational modeling techniques to characterize the structure of the B domain and that of the full-length FVIII (FL-FVIII) protein. Methods: Commercial plasma-derived and recombinant FVIII products were subjected to various chromatography methods to yield a high-pure FL-FVIII protein. The pure FL-FVIII was cross-linked using DSSO cross-linker. PNGase A enzyme was used to deglycosylate the FL-FVIII to facilitate better crosslinking. Blind modeling of the B domain was carried out on the I-TASSER server. AFM imaging studies were performed for pure FL-FVIII protein in both air and liquid. Negative staining of the purified FL- FVIII followed by two-dimensional (2D) classification was done towards future cryo-EM studies. Results and Discussion: Highly pure FL-FVIII protein of yield ≈200 µg/mL was obtained devoid of all excipients such as albumin and von Willebrand factor. Successful crosslinking of the highly pure FL-FVIII with DSSO was achieved and glycosylation residues were removed towards future XL-MS data. Blind modeling by I- TASSER server generated top three B domain models which were integrated to the available B-domain-deleted FVIII crystal structure from PDB to obtain FL-FVIII models. Negative stains of FL-FVIII showed heterogeneous particles with five different classes of size and shapes illustrated by 2D classification. AFM analysis in air and liquid modes showed high-resolution structural maps with multiple conformational possibilities of FL-FVIII. Further comparison of the low- and high-resolution structural maps obtained from negative staining and AFM imaging to our blind FL-FVIII models indicated a relative position. Conclusion: The structural imaging techniques suggest conformational variability in the FL-FVIII molecule owing to the flexibility in the FVIII B domain which is in good agreement with our blind models. This gives us a high confidence that with the addition of the experimental data to improve these blind models, we will be able to arrive at an accurate representative structure of the FL-FVIII protein. * This work was funded by IIR grant awarded to PD Dr. Arijit Biswas and Prof. Johannes Oldenburg from Takeda (Shire). Article published online: 26 October 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Multimodal Potentials of Gold Nanoparticles for Bone Tissue Engineering and Regenerative Medicine: Avenues and Prospects
Osseous tissue repair has advanced due to the introduction of tissue engineering. The key elements required while engineering new tissues involve scaffolds, cells, and bioactive cues. The macrostructural to the nanostructural framework of such complex tissue has engrossed the intervention of nanotechnology for efficient neo‐bone formation. Gold nanoparticles (GNPs) have recently gained interest in bone tissue regeneration due to their multimodal functionality. They are proven to modulate the properties of scaffolds and the osteogenic cells significantly. GNPs also influence different metabolic functions within the body, which directly or indirectly govern the mechanism of bone regeneration. Therefore, this review highlights nanoparticle‐mediated osteogenic development, focusing on different aspects of GNPs ranging from scaffold modulation to cellular stimulation. The toxic aspects of gold nanoparticles studied so far are critically explicated, while further insight into the advancements and prospects of these nanoparticles in bone regeneration is also highlighted.
Multimodal Potentials of Gold Nanoparticles for Bone Tissue Engineering and Regenerative Medicine: Avenues and Prospects
Osseous tissue repair has advanced due to the introduction of tissue engineering. The key elements required while engineering new tissues involve scaffolds, cells, and bioactive cues. The macrostructural to the nanostructural framework of such complex tissue has engrossed the intervention of nanotechnology for efficient neo‐bone formation. Gold nanoparticles (GNPs) have recently gained interest in bone tissue regeneration due to their multimodal functionality. They are proven to modulate the properties of scaffolds and the osteogenic cells significantly. GNPs also influence different metabolic functions within the body, which directly or indirectly govern the mechanism of bone regeneration. Therefore, this review highlights nanoparticle‐mediated osteogenic development, focusing on different aspects of GNPs ranging from scaffold modulation to cellular stimulation. The toxic aspects of gold nanoparticles studied so far are critically explicated, while further insight into the advancements and prospects of these nanoparticles in bone regeneration is also highlighted.
- 3 February 2022
- Published by Taylor & Francis in Nanomedicine
- Vol. 17 (4) , 237-253
A Voyage From 3D to 4D Printing in Nanomedicine and Healthcare: Part I
The transition from 3D to 4D printing has revolutionized various domains of healthcare, pharmaceuticals, design and architecture, and coating processes. The evolution from 3D printing to 4D printin... Graphical abstract
- 3 February 2022
- Published by Taylor & Francis in Nanomedicine
- Vol. 17 (4) , 237-253
A Voyage From 3D to 4D Printing in Nanomedicine and Healthcare: Part I
The transition from 3D to 4D printing has revolutionized various domains of healthcare, pharmaceuticals, design and architecture, and coating processes. The evolution from 3D printing to 4D printin... Graphical abstract
- 3 February 2022
- Published by Taylor & Francis in Nanomedicine
- Vol. 17 (4) , 255-270
A Voyage From 3D to 4D Printing in Nanomedicine and Healthcare: Part II
Recent advancements in biomedical tissue engineering are gaining wide interest. Implementing biology of living cells and organisms using technological solutions such as incorporating 4D printing an... Graphical abstract
- 3 February 2022
- Published by Taylor & Francis in Nanomedicine
- Vol. 17 (4) , 255-270
A Voyage From 3D to 4D Printing in Nanomedicine and Healthcare: Part II
Recent advancements in biomedical tissue engineering are gaining wide interest. Implementing biology of living cells and organisms using technological solutions such as incorporating 4D printing an... Graphical abstract